National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Dictionary of Cancer Terms
Send to Printer
CEP-701

 A drug being studied in the treatment of acute leukemias and some other types of cancer. It binds to a protein that is present on the surface of some types of cancer cells and stops them from dividing. CEP-701 is a type of receptor tyrosine kinase inhibitor and a type of indolocarbazole alkaloid. Also called lestaurtinib.

Previous Definitions:central nervous system prophylaxis, central nervous system sanctuary therapy, central nervous system tumor, central venous access catheter, CEP-2563 dihydrochloride
Next Definitions:cephalexin, cephalosporin, ceramide, cerebellar hemangioblastoma, cerebellopontine